Advertisement

TGFBI-associated corneal dystrophy and nephropathy: a novel syndrome?

  • China Nagano
  • Kandai Nozu
  • Tomohiko Yamamura
  • Shogo Minamikawa
  • Junya Fujimura
  • Nana Sakakibara
  • Keita Nakanishi
  • Tomoko Horinouchi
  • Yoichi Iwafuchi
  • Sentaro Kusuhara
  • Wataru Matsumiya
  • Norishige Yoshikawa
  • Kazumoto Iijima
Case Report
  • 13 Downloads

Abstract

Transforming growth factor beta-induced (TGFBI)-associated corneal dystrophies are a group of inherited progressive corneal diseases. One of these TGFBI-associated corneal dystrophies is Avellino corneal dystrophy, an autosomal dominant corneal dystrophy characterized by multiple asymmetric stromal opacities that potentially impair vision. Recently, a case with corneal dystrophy complicated by nephropathy possessing a pathogenic variant of the TGFBI gene was reported for the first time. Here, we report the second case with the same condition and the same mutation in the TGFBI gene. The patient was an 18-year-old male. He and his father had already been diagnosed with corneal dystrophy. Proteinuria was revealed in the patient during urine screening at school. Since his serum creatinine level was raised, a percutaneous renal biopsy was performed. Light microscopy demonstrated oligomeganephronia. Electron microscopy demonstrated an irregular basement membrane. TGFBI was analyzed by direct sequencing. A heterozygous mutation c.371G > A in exon 4, which caused an amino acid substitution from arginine to histidine at codon 124, was identified in the patient and his father. Although only one case of TGFBI-associated corneal dystrophy and nephropathy has been reported, our case’s clinical and pathological findings were almost identical to those in that reported case. Further investigations of this new disease entity should be reported to all nephrologists and ophthalmologists.

Keywords

Avellino corneal dystrophy TGFBI Renal dysfunction Electron microscopy 

Notes

Acknowledgements

This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (subject ID: 18K15713 to China Nagano).

Compliance with Ethical Standards

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of Kobe University Graduate School of Medicine (IRB approval number 301) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors have nothing to disclose.

References

  1. 1.
    Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992;11(7):511–22.  https://doi.org/10.1089/dna.1992.11.511.CrossRefPubMedGoogle Scholar
  2. 2.
    Lakshminarayanan R, Chaurasia SS, Anandalakshmi V, Chai SM, Murugan E, Vithana EN, et al. Clinical and genetic aspects of the TGFBI-associated corneal dystrophies. Ocul Surf. 2014;12(4):234–51.  https://doi.org/10.1016/j.jtos.2013.12.002.CrossRefPubMedGoogle Scholar
  3. 3.
    Lee JH, Cristol SM, Kim WC, Chung ES, Tchah H, Kim MS, et al. Prevalence of granular corneal dystrophy type 2 (Avellino corneal dystrophy) in the Korean population. Ophthalmic Epidemiol. 2010;17(3):160–5.  https://doi.org/10.3109/09286581003624939.CrossRefPubMedGoogle Scholar
  4. 4.
    Fujiki K, Nakayasu K, Kanai A. Corneal dystrophies in Japan. J Hum Genet. 2001;46(8):431–5.  https://doi.org/10.1007/s100380170041.CrossRefPubMedGoogle Scholar
  5. 5.
    Iwafuchi Y, Morioka T, Oyama Y, Nozu K, Iijima K, Narita I. A case of transforming growth factor-beta-induced gene-related oculorenal syndrome: granular corneal dystrophy type II with a unique nephropathy. Case Rep Nephrol Dial. 2016;6(3):106–13.  https://doi.org/10.1159/000449129.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Dyrlund TF, Poulsen ET, Scavenius C, Nikolajsen CL, Thogersen IB, Vorum H, et al. Human cornea proteome: identification and quantitation of the proteins of the three main layers including epithelium, stroma, and endothelium. J Proteome Res. 2012;11(8):4231–9.  https://doi.org/10.1021/pr300358k.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Taketani Y, Kitamoto K, Sakisaka T, Kimakura M, Toyono T, Yamagami S, et al. Repair of the TGFBI gene in human corneal keratocytes derived from a granular corneal dystrophy patient via CRISPR/Cas9-induced homology-directed repair. Sci Rep. 2017;7(1):16713.  https://doi.org/10.1038/s41598-017-16308-2.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  • China Nagano
    • 1
  • Kandai Nozu
    • 1
  • Tomohiko Yamamura
    • 1
  • Shogo Minamikawa
    • 1
  • Junya Fujimura
    • 1
  • Nana Sakakibara
    • 1
  • Keita Nakanishi
    • 1
  • Tomoko Horinouchi
    • 1
  • Yoichi Iwafuchi
    • 2
  • Sentaro Kusuhara
    • 3
  • Wataru Matsumiya
    • 3
  • Norishige Yoshikawa
    • 4
  • Kazumoto Iijima
    • 1
  1. 1.Department of PediatricsKobe University Graduate School of MedicineKobeJapan
  2. 2.Department of Internal MedicineKoseiren Sanjo General HospitalSanjoJapan
  3. 3.Department of OphthalmologyKobe University Graduate School of MedicineKobeJapan
  4. 4.Clinical Research CenterWakayama Medical UniversityWakayamaJapan

Personalised recommendations